about
Proteomics reveals the effects of sustained weight loss on the human plasma proteomeNOREVA: normalization and evaluation of MS-based metabolomics data.Genetic regulation of adipose tissue transcript expression is involved in modulating serum triglyceride and HDL-cholesterol.Metabolic Responses of Eisenia Fetida to Individual Pb and Cd Contamination in Two Types of SoilsImpaired branched-chain amino acid metabolism may underlie the nonalcoholic fatty liver disease-like pathology of neonatal testosterone-treated female rats.Metabolomics applied to islet nutrient sensing mechanisms.Maternal obesity and increased neonatal adiposity correspond with altered infant mesenchymal stem cell metabolism.A Serum Small Molecule Biosignature of Radiation Exposure from Total Body Irradiated Patients.A Decade of Genetic and Metabolomic Contributions to Type 2 Diabetes Risk Prediction.Boosted TCA cycle enhances survival of zebrafish to Vibrio alginolyticus infection.Development of suspension cell culture model to mimic circulating tumor cells.Cardiovascular Metabolomics.The BCKDH Kinase and Phosphatase Integrate BCAA and Lipid Metabolism via Regulation of ATP-Citrate Lyase.Robust volcano plot: identification of differential metabolites in the presence of outliers.Untargeted metabolomic on urine samples after α-lipoic acid and/or eicosapentaenoic acid supplementation in healthy overweight/obese women.A Metabolomics Study on the Bone Protective Effects of a Lignan-Rich Fraction From Sambucus Williamsii Ramulus in Aged RatsThe induction of the fibroblast extracellular senescence metabolome is a dynamic processl-Alanine activates hepatic AMP-activated protein kinase and modulates systemic glucose metabolism
P2860
Q34547857-0AD26001-1C59-4462-B48A-1B7D40AF3E49Q34556970-7501FE85-807A-48BA-9E79-7A157E6D3BE3Q38606656-39549550-FFDA-4B56-9669-41B0E3AF0783Q42376020-351D3A6E-EBF1-483B-B625-74C12F8C3722Q42377175-0E2C7AB5-5891-47B4-93A6-53673A02B05DQ42514551-6C7B237C-5DE6-4C18-959A-DF8D566998E6Q47673849-6E06767B-400C-4341-A2D4-97FBF965A3E8Q48211090-97B94A0E-0D62-493B-8E31-BFEBB0B66DEFQ48561722-3387B34E-4462-48F1-A940-CDD3FBA4AD70Q50025358-D8107A87-EDA0-4A13-8AA8-CED16234A850Q50128323-21692868-35A3-4616-B990-D3405FED0D61Q52560349-6E5FF4A3-C5FC-4D59-975A-66DFF8D60E63Q54108559-27A53117-5ED0-4B8E-A596-4D7CC38C4790Q55265458-37272C69-FF74-403C-A06C-21BF65EF0EC3Q55398526-BD44D1FB-D63C-4626-9866-B8DAE5BA679BQ58728809-FC985EF7-5E90-423F-B608-834EDC7B1E09Q58782977-69A1A46B-FA48-48F2-A5E2-D99A5726CFBAQ58788013-64D1681D-4671-4F69-ADD0-72981E584749
P2860
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Metabolomics and Metabolic Diseases: Where Do We Stand?
@en
type
label
Metabolomics and Metabolic Diseases: Where Do We Stand?
@en
prefLabel
Metabolomics and Metabolic Diseases: Where Do We Stand?
@en
P2860
P1433
P1476
Metabolomics and Metabolic Diseases: Where Do We Stand?
@en
P2093
Christopher B Newgard
P2860
P356
10.1016/J.CMET.2016.09.018
P577
2016-10-27T00:00:00Z